Home » Authors » Trista Morrison

Articles by Trista Morrison

CytRx Spins Out RNAi Programs To Form Subsidiary RXi Pharma

Jan. 11, 2007

By Trista Morrison

CytRx Spins Out RNAi Programs To Form Subsidiary RXi Pharma

Jan. 11, 2007

By Trista Morrison

Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena

Jan. 5, 2007

By Trista Morrison

Biogen Idec Acquires Syntonix, Moves Into Hemophilia Arena

Jan. 5, 2007

By Trista Morrison

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Jan. 3, 2007

By Trista Morrison

Biomira Launches Clinical Trials Of Cancer-Fighting Therapies

Jan. 3, 2007

By Trista Morrison

Paramount-Backed Tikvah Makes Reduced-Risk CNS Play

Dec. 29, 2006

By Trista Morrison

Paramount-Backed Tikvah Makes Reduced-Risk CNS Play

Dec. 29, 2006

By Trista Morrison

EpiCept Licenses Bupivacaine Patch IP To Durect For $10M

Dec. 27, 2006

By Trista Morrison

Ardea Biosciences Acquires Valeant's Early Programs

Dec. 27, 2006

By Trista Morrison

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...